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Background: Non-adherence and drop-out are major problems in pain rehabilitation. For patients with various
health problems, motivational interviewing (MI) has shown promising effects to tackle these problems. In chronic
pain patients, the effectiveness of MI is however unknown. Therefore, a MI-based pre-pain rehabilitation
intervention (MIP) addressing motivation, expectations, and beliefs has been developed to prepare eligible patients
for rehabilitation treatment.
Methods/design: Study design: A parallel randomized controlled trial including two interventions: a motivational
interviewing pre-pain rehabilitation intervention (MIP) and a usual care (UC) control arm. Follow-up will be 6
months after completion of rehabilitation treatment.
Study population: One hundred and sixty (n = 80 per arm) patients with chronic non-specific musculoskeletal pain
visiting an outpatient rehabilitation department, who are eligible to participate in an outpatient cognitive
behavioral pain rehabilitation program.
Intervention: MIP consists of two sessions to prepare and motivate the patient for pain rehabilitation treatment and
its bio psychosocial approach. UC consists of information and education about the etiology and the general
rehabilitation approach of chronic pain. Both the MIP and UC contain two sessions of 45 to 60 minutes each.
Objective: The aim of the current study is to evaluate the effectiveness of MIP compared to UC in terms of an
increase in the long-term level of societal participation and decrease of drop-out during rehabilitation treatment.
Main study endpoints: Primary outcome is the change in level of participation (according to the ICF-definition:
‘involvement in a life situation’) 6 months after completion of rehabilitation treatment. Secondary outcomes are
adherence and treatment drop-out, disability, pain intensity, self-reported main complaints, (pain-specific) self-
efficacy, motivation, and quality of life. Costs are calculated including the costs of the pre-treatment intervention,
productivity losses, and healthcare utilization. Potential moderators and active ingredients of MI are explored. For
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the process evaluation, parameters such as MI fidelity, feasibility, and experiences are explored.
Discussion: The results of this study will provide evidence on the effectiveness of this MI-based pre-treatment in
pain rehabilitation. Furthermore, a cost-effectiveness analysis and exploration of moderating and working
mechanisms of MI and an extensive process evaluation takes place.
Trial registration: Nederlands trial register NTR3065
Keywords: Motivational interviewing, Motivation, Adherence, Design article, Drop-outs, Working mechanism,
Mediators/moderators, Societal participationBackground
Chronic non-specific musculoskeletal pain is a major
health burden. It occurs in approximately 10% of
the general population [1] and causes disability [2],
medical expenses [3], and a high amount of work absen-
teeism [4].
In the Netherlands, cognitive behavioral therapy
(CBT)-based approaches are part of usual rehabilitation
care for patients with non-specific chronic pain [5], and
also recommended in the Dutch guidelines [6]. The
common assumption of CBT in rehabilitation is that
pain and disability are not only influenced by biomedical
factors but also by psychological and social factors,
which is referred to as the bio psychosocial approach
[7]. The primary aim of rehabilitation treatment is to
increase the patient’s ability to cope with pain instead
of curing pain. The ultimate intention is to increase
the patient’s level of participation in society and his/
her quality of life [8]. The ultimate goal and key out-
come of rehabilitation is therefore societal participa-
tion. According to the International Classification of
Functioning, Disability and Health (ICF), participation
is therein defined as ‘involvement in a life situation’
whereas the opposite, participation restrictions, are defined
as ‘problems an individual may experience in involvement
in life situations’ [9].
The Initiative on Methods, Measurements, and Pain
Assessment in Clinical Trials (IMMPACT) does not men-
tion the measurement of participation [10]. But in the field
of rehabilitation, participation is seen as an important
concept in order to reflect meaningful patient-centered
outcomes [11]. It is suggested that those outcomes should
be included more often in trials [12].
Reviews have shown a moderate effectiveness of cogni-
tive behavioral treatments in chronic non-specific mus-
culoskeletal pain [13] and low back pain [14]. Behavioral
therapy is more effective than usual care in terms of pain
relief [15], and similar effects are shown for functioning
after an intensive multidisciplinary bio-psycho-social re-
habilitation program [16].
Unfortunately, in the current rehabilitation care, non-
adherence and drop-out are major problems. Adherence
rates are low in patients with chronic conditions [17],and subsequently, drop-out of pain rehabilitation
programmes, ranging from 9% to 42%, is high [18-20].
Previous research showed that adherence and non-drop
-out of treatment is related to a better outcome in phys-
ical and emotional functioning and pain severity [21].
Adherence is influenced by multiple factors such as the
healthcare provider-patient relationship, the patient’s
self-efficacy to be able to make changes [22], and the pa-
tient’s satisfaction with improvement [23].
In order to improve adherence and motivation to pre-
vent drop-out, and to strengthen self-efficacy, motiv-
ational interviewing (MI) has been proposed [24]. Miller
and Rollnick, the founders of MI, defined it as ‘directive,
client-centred counselling style for eliciting behaviour
change by helping clients to explore and resolve ambiva-
lence’ [25]. The overall goal is to increase the client’s in-
trinsic motivation to change and enhance behavioral
change [26]. MI was originally developed for problem
drinkers [27] and in the beginning applied in the addic-
tion field only (for example, [28,29]). Meta-analyses
showed that using MI as a pre-treatment yielded the
best outcomes compared with other active treatments
[30-32]. Therein, MI was designed to prepare clients for
further treatment such as CBT or an inpatient program.
Furthermore, the effective application ranged from a var-
iety of disorders such as addiction (except smoking
cessation), increasing healthy behaviors, and the man-
agement of chronic illnesses. MI as treatment approach
is fairly new in the field of chronic pain. MI has been ap-
plied with promising results in two small randomized
controlled trials (RCTs) within primary care for patients
with chronic pain conditions. Habib et al. [33] found
significant increases in attending self-management
workshops after a psychologist-led two-session MI-
based feedback interview compared with an attention
placebo interview [33]. Another recent study found a
MI-adapted intervention added to outpatient physio-
therapy for patients with back pain effective in enhan-
cing motivation and exercise adherence compared to
physiotherapy alone [34].
With the results of these studies in mind, it is seems
promising to explore the effects of MI on non-adherence
and drop-out in chronic pain rehabilitation care, and
Mertens et al. Trials 2013, 14:90 Page 3 of 14
http://www.trialsjournal.com/content/14/1/90participation afterwards, where patients are characterized
by a high levels of disability and complex problems.
Aims
The primary objective of this current project is to study
the effectiveness of MI by means of the MIP interven-
tion. The interventions aims at decreasing drop-out rate
and increasing adherence to treatment program to
reach a high level of societal participation ultimately in
patients with non-specific musculoskeletal chronic
pain, who have been selected for pain rehabilitation
treatment.
The main research questions are:
1. What is the effectiveness of MI-based pre-treatment
(MIP) compared to usual care (UC) on the level of
participation, treatment drop-out rate, and
adherence in patients with chronic non-specific
musculoskeletal pain following pain rehabilitation?
2. What is the cost-effectiveness and cost-utility of
MIP, compared to UC from a societal perspective?
3. What is the feasibility of the MIP intervention in
terms of MI fidelity (process evaluation)?
4. What are experiences of nurses and patients in
terms of satisfaction with and barriers of the MIP
intervention (process evaluation)?
Hypotheses
1a. It is expected that patients’ level of social
participation will be higher in the MIP intervention
condition compared to the UC after pain rehabilitation
treatment and at 6-month follow-up after finishing the
rehabilitation treatment.
1b. It is hypothesized that drop-out rates will be lower
and adherence to the treatment and the level
performing daily activities) will be higher in the MIP
condition compared to the UC.
2. It is hypothesized that MIP will be more efficient
compared to UC, both in effects as well as utilities.
3. It is hypothesized that the MIP intervention is
feasible for the participating nurses and the MI fidelity
of the MIP intervention is sufficient.
Methods/Design
Study design
The PREPARE study is a parallel single-blind RCT.
Recruitment
Participants will be recruited from the outpatient depart-
ment of Rehabilitation Medicine in an academic and a re-
gional hospital in the Southern part of the Netherlands,
starting in January 2012 and lasting till June 2013.Patients visiting one of the participating outpatient re-
habilitation departments for an intake interview will be
evaluated whether they are eligible for rehabilitation
treatment by the consultant in rehabilitation medicine.
Participants
Participants are patients who meet the inclusion criteria
as stated below.
In current care, patients are selected for rehabilitation
treatment by the consultant in rehabilitation medicine
based on expert opinion. For this, both medical (origin
and severity of the pain problem and interfering co-
morbidity) and motivational factors are evaluated. In pa-
tients eligible for outpatient pain rehabilitation treatment,
additional inclusion and exclusion criteria for participation
in the PREPARE study are checked and in case of eligibil-
ity, patients will be invited to participate.
Inclusion criteria are: non-specific chronic (duration >3
months) musculoskeletal pain; age between 18 and 65
years; the chronic pain syndrome is not attributable to a
recognizable, known specific pathology (for example, infec-
tion, tumor, osteoporosis, fracture, structural deformity, in-
flammatory disorder (for example, ankylosing spondylitis);
medium to high level of motivation for pain rehabilitation
from the consultant’s perspective; adequate literacy to
complete assessment measures.
Exclusion criteria: pregnancy; surgery planned in the
foreseeable future; patient involved in litigation proce-
dures; suspicion of a psychiatric disease that will inter-
fere with rehabilitation treatment (according the expert
opinion of the consultant in rehabilitation medicine).
Sample size
The sample size calculation is based upon an estimated
difference in change in level of participation between
baseline and 6-month follow-up (after completion of the
rehabilitation treatment) as assessed by the Utrecht Scale
for Evaluation of Rehabilitation-Participation (USER-P)
[35,36]. Reproducibility [37], responsiveness [38], and val-
idity [37] of the USER-P are satisfactory. As participation
is the important outcome in rehabilitation, we have
chosen this as primary outcome. The scale consists of the
three aspects of participation represented by the subscales
Frequency, Restriction, and Satisfaction. The sum score of
each subscale is converted to scores on a scale ranging
from 0 to 100. There is no USER-P total score.
Our sample-size calculation is based upon the subscale
Satisfaction. This subscale is the most important part of
participation as it marks the subjective experience of
participation [9]; therefore we have chosen this one.
As at this moment no information is available about
the USER-P in a pain population regarding normative
values, clinically relevant change, and clinically relevant
difference, our study is exploratory of character. In a
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ferent patient groups at three different points in time
[38]. As these groups were part of a cohort study, noth-
ing is known about differences after a specific treatment.
We know from other studies that multidisciplinary pain
rehabilitation treatment is moderately effective with
effect sizes ranging from 0.30 for behavioral outcomes
up to 0.40 for functional outcomes [14]. We expect an
additional effect for the MIP intervention since systematic
reviews of motivational interviewing-based interventions
show an effect size ranging from 0.27 up to 0.40 when
compared with a weak comparison group [30-32,39]. It
has to be said that in those reviews no study in the field of
chronic pain or rehabilitation treatment was taken into
account. Therefore, our power calculation is based on the
following two assumptions:
1. Using an expected mean change of 5 points within
UC is expected whereas a difference of additional 5
points (thus at least 10 points in total) within MIP
in the USER-P sub scale Satisfaction is considered as
clinically relevant. Those numbers are estimates as
the clinically relevant difference is not known yet.
2. Assuming a standard deviation of 10 points in both
groups, the standardized effect size, Cohen’s d, is
(10–5)/10 = 0.5 indicating a medium additional
effect size of the MIP [40].
Assuming power (1-β) of 80%, α = 0.05, two-sided test-
ing, and holding the above mentioned assumptions,
would necessitate n = 128 participants (n = 64 per arm).
With an expected total drop-out of 20% (10% drop-out
from the study, another 10% drop-out during the usual
rehabilitation treatment as our unsystematic registration
has shown), n = 160 (n = 80 per arm) was chosen as the
optimal total sample size. Additionally, as the recruit-
ment of 160 participants in the region of South-Limburg
/the Netherlands is feasible in a time range of 18
months, we have chosen for this amount of participants.
Informed consent, randomization, and blinding
Standard informed consent procedures will be used. After
having received informed consent, the participants are
randomly assigned to either the experimental intervention
condition (MIP) or the control condition (UC). Block
randomization with block size of four are used per study
site (hospital) to obtain equal numbers in both arms.
An independent research assistant will execute the
randomization by means of a computerized random num-
ber generator resulting in a computer-generated list of
random numbers to allocate the participant either to the
experimental or the control condition. The consultant in
rehabilitation medicine, the rehabilitation team and the
participant will all be blind for the result of the allocationto the UC or the MIP but not for participation in the
study at all. The research assistant responsible for the
logistics of the present study and the participating
nurses administering the intervention and control con-
dition are not part of the treatment team and are not
blinded for allocation.
Treatment
To understand the features of both PREPARE condi-
tions, first current care in pain rehabilitation in the
Netherlands will be explained. Thereafter, both PRE-
PARE conditions are described. At last, the role of the
nurses is illustrated.
Current care in pain rehabilitation
In the current pain rehabilitation treatment in the
Netherlands [41] roughly four phases can be identi-
fied. The specific content of the phase can differ per
center.
The four phases are:
1. Screening: In this phase, a patient’s eligibility and
readiness for pain rehabilitation is assessed. Also
information is provided by either a consultant in
rehabilitation medicine or a nurse practitioner. In
most centers for this purpose use existing
educational material, such as ‘De pijn de baas’
(‘Mastering pain’) [42] or ‘Explain Pain’ [43] (WPN,
2012, internal document) are used as information
tools for this purpose. In most places, information is
given before the definite start of the treatment.
2. Observation: A patient’s pre-treatment situation and
motivation is assessed, and the most suitable type of
treatment is selected. In some centers, this phase
takes two or three sessions in 2 to 4 weeks. Often
this is accompanied by the use of self-report
questionnaires.
3. Rehabilitation treatment: The multidisciplinary pain
rehabilitation treatment lasts for around 3 months
with an intensity of 2 or 3 days a week on average.
Depending on the patients’ limitations and
underlying problems, different treatment approaches
such as graded activity and/or graded exposure are
used in combination with other psychosocial and
physical interventions.
4. Aftercare and post rehabilitation treatment
assessment: Booster sessions, tailored to patients’
needs, are given for relapse prevention and long-
term facilitation of applying learned skills to
maintain and further improve participation. The
moment of the assessment is around 6, 12, 24, to 52
weeks post-treatment. These follow-up
appointments are mostly accompanied by
completion of self-report questionnaires for
Mertens et al. Trials 2013, 14:90 Page 5 of 14
http://www.trialsjournal.com/content/14/1/90treatment evaluation. It has to be said that this is
not routine care in all Dutch rehabilitation centers.
PREPARE conditions
The PREPARE intervention focuses on phase one. This
is also the period during which patients are waiting
before they can start their actual treatment (observation
and rehabilitation treatment). During the study, patients
will receive either the new MI-based intervention or care
as usual. In order to standardize treatment options, both
arms (MIP as well as UC) will include two sessions with
identical contact time. In order to prevent contamination
of treatment, each treatment condition will be delivered
by different nurses. Figure 1 illustrates the situation during
the PREPARE study.
1. Usual care (UC)
In the usual care (UC) arm, participants will receive
pain education according to the information ‘De pijn de
baas’ [40] (Mastering pain). The ultimate goal is to pro-
vide the participant with information about, for example,MI-based pre-treatment 
Intervention condition 
(2 sessions of 1 hour)
Intake interview rehabilita
Randomisation
C
(2 s
Informed consent p
Assessment
Indication for trea
Start rehab 
treatment
Evaluation after the 
treatment
T0: After randomisation +inclusion
T1: After two sessions intervention/ control condition
T2: After multidisciplinary assessment (~6 weeks after T
T3: After finishing pain rehab (takes ~12 weeks)
T4: 6 months after finishing the pain rehab treatment
Ev
Figure 1 Flow-chart of the design of the PREPARE study (apart file).differences between acute and chronic pain, its nature,
and strategies to handle cognitions about pain.
2. MIP intervention condition
The MI intervention condition is based on the four
general principles of MI, which are incorporated into all
sessions in the MIP condition [44]:
1. Expressing empathy by the use of reflective listening,
2. Developing discrepancy between client goals and
current problem behavior,
3. Rolling with resistance by avoiding argumentation by
assuming that the client is responsible for the
decision to change,
4. Supporting self-efficacy and optimism for
change [44].
The features of both MIP and UC are mentioned in
Table 1.
The nurse is directive within this process, but the
participants’ autonomy is strengthened and his or hertion consultant
Pain education
ontrol condition
essions of 1 hour) 
atient
T0:Baseline  
measurement
TIM
E
T4: 6 months after 
T3
T1: 
Post pre-treatment 
tment
1) 
T2: After 
assessment 
T3: Post treatment  
evaluation
aluation after the 
treatment
Assessment
Start rehab 
treatment
Table 1 Features of the two interventions
Motivational interviewing based pre-treatment (MIP) Pain education (Usual care (UC))
Goal: explore participant’s life situation, impairments and
ambivalences in order to enhance intrinsic motivation
Goal: provide the participant with
information
Goal
General principles of MI General principles of health education and
patient education
Basic principle
Content based on patient-driven topics derived from
the ICF-model
Content based on the book ‘De pijn de
baas’ [42] (Mastering pain)
Foundation
Content sessions tailored to the patients’ readiness to change Content is fixed by means of the treatment
protocol
Protocol rigidity
Exploration actual (life) situation, burden and impairments
of the chronic pain in daily life
Provision of general health education about
topics related to chronic pain
Content first session
Assessing + enhancing motivation, self-efficacy, and readiness
to change for behavior
Provision of information regarding core
elements of pain rehabilitation
Giving feedback adapted to the state of readiness-to-change Continuation of general health education
about topics related to chronic pain
Content second session
Continuation exploration
Continuation assessing + enhancing motivation, self-efficacy,
and readiness to change for behavior
Is given related to the stage of change of the participant
according to the MI-principles
Is not given Feedback
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respected.
During the first appointment, a trustful relationship
between participant and nurse is built, the actual (life)
situation, burden, and impairments of the chronic pain
in daily life, motivation, self-efficacy, and readiness to
change behavior is assessed and enhanced. Next, the ses-
sion is summarized and closed. The second appointment
starts with a brief motivational feedback session. The
process of the first appointment will be discussed with
the participant by giving feedback adapted to the state of
readiness-to-change. Therein, motivation and self-efficacy
for behavior change is enhanced. In addition, topics re-
lated to chronic pain and treatment, such as education
about the influence of exercise and a background in the
bio psychosocial approach will be discussed. Next, the ses-
sion is summarized and closed.
Nurses
Both UC and MIP are administered by registered nurses
working in the field of rehabilitation. In order to prevent
contamination of treatment by components of the other
intervention, nurses will be trained and only guide par-
ticipants in one specific condition. The two nurses se-
lected to deliver the MI condition, are both experienced
MI coaches (4 years of experience). To assure optimal
quality of the MI condition, both nurses receive an ex-
pert training by a certified MI trainer: their MI know-
ledge and experience in the context of chronic pain
rehabilitation are updated based on an evidence-based
training tailored to their specific needs [45-49]. During
the study the MI sessions will also be audio taped andthe MI quality will be assessed using a coding instru-
ment (Motivational Interviewing Treatment Integrity
(MITI)) (see also Methods section, Process evaluation
section). Subsequent training will be based on addition-
ally regular supervision, done by training on the job and
direct feedback on MIP sessions.
Quality of the UC condition:
The two nurses selected to deliver the usual care con-
dition are experienced in the field of rehabilitation (20
years and 5 years, respectively).
Before the start of the study, they will receive a 3-h re-
fresher training in general communication skills and
general principles of health education. In addition, the
content of relevant chapters of the book ‘Mastering pain’
is discussed. During the study, the nurses of the UC con-
dition will meet once or twice a year to discuss problems
encountered during the sessions.
Data collection
For the (cost-) effectiveness evaluation, measurements
will be carried out before the first MIP/UC pre-
treatment sessions (T0), after the MIP/UC (T1 = post
pre-treatment), after the regular multidisciplinary pre-
rehabilitation assessment (before starting rehabilitation),
at the start of the pain rehabilitation treatment (T2),
after treatment completion (T3), and at 6-month follow-
up (T4). Study assessments at T0, T2, and T3 will be
integrated in current care clinical assessment battery
pre-rehabilitation and post rehabilitation (see also
Figure 1 (flow-chart) and Table 2). Cost measurements
will be carried out at three points: T0, T2, and T4. Infor-
mation on drop-out from and adherence to the (pre-)
Table 2 Outcome measures, abbreviation instrument, and assessment moments PREPARE study
Baseline Two
sessions
After pre-
treatment
Start pain rehab
treatment
Finish pain
rehab treatment
6 months
after T3
Abbr. T0a T1 T2a T3a T4
Covariates
Demographics patient x
Primary outcome
effect evaluation
Participation USER-P x x x x
Secondary outcomes
effect evaluation
Physical functioning/disability PDI x x x x
Pain intensity VAS x x x x
Main complaints PSC x x x x
Drop-out/adherence # #
Self-efficacy/perceived competence GSE x x x x
Pain-specific self-efficacy scale CPSS_V2 x x x x
Cost-effectiveness
evaluation
Cost questionnaire Tic-P x x x
Productivity losses SF-HLQ x x x
Quality of life/health status SF-36 x x x x
Potential active
ingredients MI
Stages of change MPRCQ 2 x x
MI integrity/fidelity *
Potential moderators
Credibility and expectancy
of the treatment
CEQ x x x
Motivation TMQ x x
Depression BDI x x x
Acceptance AAQ-II x x x
Flexible goal-adjustment FGA x x x
Process evaluation
Satisfaction with
(pre-)treatment
x +
Client-centeredness CCCQ x
Feasibility +
x Questionnaires in patients.
+ Questionnaire in nurses.
# Process measures.
* Audiotapes.
aAlongside usual care assessment.
Mertens et al. Trials 2013, 14:90 Page 7 of 14
http://www.trialsjournal.com/content/14/1/90rehabilitation treatment, start and end date of the treat-
ment, and no show are derived from the administrative
patient registry.
As patients have to incorporate learned behavior into
daily routine functioning, the improvement of participation,
the ultimate goal of pain rehabilitation, is not optimal
directly after treatment. We expect relevant change in the
level of participation to occur at 6 months. Therefore this
time point is chosen as our last measurement moment.
Due to the fact that the PREPARE trial is embedded inclinical practice, the measurement moments are not pre-
cisely planned at the same moment. Especially the waiting
list period between T1 and T2 may vary and furthermore
the total duration of the pain rehabilitation treatment may
vary between 10 to 16 weeks.
Demographic and medical variables
Baseline assessment includes: gender, nationality, marital
status, educational level, and co-morbidity, as well as
pain location and pain duration.
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risk factors for attrition: sick leave [50], level of being
active in sports, smoking status [18], level of physical
functioning [50], pain intensity [50,51], perceived disability
[51], low treatment satisfaction [52], and expectations
regarding the content of the treatment [53].
Outcome measures
Outcome measures (parameters) and assessment moments
are presented in Table 2.
Primary outcome
The primary outcome of the effect-evaluation will be the
mean difference in change in level of participation of the
participants at T4 compared to T0 (baseline).
Participation will be measured by the Utrecht Scale for
Evaluation of Rehabilitation-Participation (USER-P) [54]. It
consists of 32 items and covers three aspects of participa-
tion, namely Frequency, Restriction, and Satisfaction. The
subscale Frequency consists of 12 items and assesses voca-
tional activities, and frequency of leisure activities and social
activities. Each item is scores from 0 (‘not at all’) up to 5
(‘36 hours or more’/’19 times or more’). The subscale
Restriction comprises 10 items assessing experiences in
vocational and leisure activities. Items are rated on a four-
point Likert scale ranging from 0 (‘not possible at all’) to 3
(‘independent without disability’). The subscale Satisfaction
consists of 10 items and rates satisfaction regarding partici-
pation in daily life issues such as work and social relations.
Items are rated on a five-point Likert scale ranging from 0
(‘not satisfied at all’) to 4 (‘very satisfied’). Higher scores re-
flect more social participation (each higher frequency, less
restrictions, higher satisfaction). The psychometric qualities
validity and reproducibility are satisfactory [36,55].
Secondary outcomes
Level of performing daily activities resulting from
chronic pain will be measured by the Pain Disability
Index (PDI) [56], which consists of seven items using an
11-point Likert scale ranging from 0 (no disability) to 10
(total disability). A total score is derived by summing up
the item responses, ranging from 0 up to 70, with a
higher score indicating more disability [56]. Good psy-
chometric properties of the PDI have been shown and
normative data are available [57].
Pain intensity is assessed by a 100-mm Visual Analogue
Scale (VAS). The VAS is a common and valid tool for
measuring pain intensity [58].
In order to assess the participant’s self-reported main
complaints, the Patient Specific Complaints question-
naire (PSC) will be used [59,60]. The participant selects
three to five most limited functional activities and rates
the difficulty to perform them during the previous week
on a 100-mm VAS [60]. It is tested as valid, reliable, andresponsive in patients with chronic musculoskeletal
pain [61,62].
Drop-out will be registered in the patient registry in the
institution. Each patient will be classified as either a par-
ticipant who has completed the pain rehabilitation pro-
gram as proposed or who has dropped out prematurely. In
addition, the attendance of each treatment session will be
assessed. The level of adherence to the pre-treatment
intervention (MIP and UC) is computed by dividing the
number of the PREPARE sessions that an individual
participant actually has attended by the number of two
pre-treatment sessions as planned.
Adherence to the rehabilitation treatment is computed
by dividing the number of scheduled treatment sessions
(which amount is tailored to the participants’ needs) by
the actual attended number of visits. This method has
been reported extensively in the literature as a measure
of adherence to rehabilitation [63].
General self-efficacy is assessed by the Dutch General
Self-efficacy questionnaire [64]. Ten items ranging from
‘totally untrue’ up to ‘totally true’ assess coping in general
life demands. A confirmatory factors analysis has taken
place in elderly [65] showing a good fit.
A disease-specific self-efficacy measure is used, namely
the Chronic Pain Self-efficacy Scale (CPSS) consisting of
22 items the three subscales pain management, coping,
and physical function. It offers good overall internal
consistency and acceptable test-retest reliability [66].
Cost-effectiveness and cost-utility
To evaluate the economic effects of MIP and UC, relevant
cost categories of resource use and volumes of these cat-
egories will be measured. Finally, volumes are multiplied
by the corresponding costs.
The direct (non-)healthcare costs will be assessed with
the Trimbos/iMTA questionnaire for Costs associated
with Psychiatric Illness (Tic-P) [67]. This self-reporting
questionnaire consists of 15 items and assesses
healthcare use in a recall period of 3 months.
Productivity losses are assessed by the Short Form
Health and Labor Questionnaire (SF-HLQ) [68]. The
SF-HLQ measures the extent of production losses of
paid and unpaid work in four modules: absence from
work, reduced productivity at paid work, unpaid labor
production, and impediments to paid and unpaid labor.
It consists of 11 items.
For the cost valuation, standardized cost prices will be
used from the Dutch manual for cost analysis in
healthcare research [69]. Where no standard cost prices
are available, real costs or tariffs will be used to estimate
costs. Productivity losses will be calculated based on the
friction costs method. Cost prices will be presented in
Euros and the baseline year is 2012, or otherwise
discounted. The discounting rate of costs is 4%, and
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costs per patient-year will be calculated.
For the cost-effectiveness analysis (CEA), costs will be
weighted against the primary outcome measure partici-
pation. The measure is described above.
For the cost-utility analysis (CUA), costs per year will be
weighed against utilities based on the SF-36. The SF-36 is
a reliable and valid instrument to measure health-related
quality of life [71]. Utilities are values or preferences that
respondents assign to a particular health state and are
overall expressed on a scale ranging from 0 to 1 [72]. The
utilities used in this study will be derived with an algo-
rithm of the SF-6D, which estimates utilities based on the
health-related quality of life scores of the SF-36 [73]. Fur-
thermore, the utilities will be estimated by an algorithm of
Brazier, Roberts, and Deverill (2002). The derived utilities
at three measurement points (T0, T2, T4) will be used to
compute the Quality Adjusted Life Years (QALY) score by
means of the area under the curve method [74]. This
means that the weights for each health state (utilities)
will be multiplied by the time in that particular health
state and then summed to calculate the total number
of QALYs.
MI-specific possible active ingredients
Resulting from the existing literature on MI, potential
specific active ingredients were identified and will be
assessed in this study [75,76].
The stage of change is assessed by the Multidimensional
Pain Readiness to Change Questionnaire 2 (short version).
It measures the chronic pain participants’ readiness to
change. The questionnaire is based upon the trans the-
oretical model of behavior change of Prochaska and
DiClemente. The MPRCQ2-26 consists of 26 items and is
scored on a seven-point Likert scale [77]. Psychometric
properties are evaluated and appeared to be satisfactory
[78]. To be able to take it into account as possible moder-
ator, it is measured before and after the pre-treatment.
MI integrity is hypothesized to be another working
mechanism for MI. It is further explained below under
the heading ‘MI integrity and fidelity’.
Possible moderators
We will also measure specific individual factors at
baseline that could influence the treatment effect.
From the literature, a number of psychosocial attri-
butes moderating the effects of the pain rehabilitation
treatment are identified [79].
Research has shown the influential role of expectancy
on treatment outcome in pain rehabilitation [80,81].
Credibility and expectancy is measured by an adapted
and translated version of the Credibility and Expectancy
Questionnaire (CEQ) [82]. In two parts, participants are
asked to rate in total five items related to the credibilityand expectancy regarding pain rehabilitation treatment.
Credibility and expectancies regarding the treatment
have to be rated in two items. In another item the
expected success in terms of an improvement in participa-
tion, decrease in disability, and decrease in pain intensity
are rated. The CEQ uses a rating scale, ranging from 1
(not at all) to 9 (very much). Good psychometric prop-
erties have been demonstrated and the same factors
structure was confirmed [82].
Motivation is assessed by the Treatment Motivation
Questionnaire (TMQ). The TMQ assesses intrinsic and
extrinsic information about entering and remaining in
treatment [83]. It consists of 26 items to be rated on a
five-point Likert scale ranging from 1 (not at all true) up
to 5 (very much true). The factors internal and external
motivation, interpersonal help seeking and confidence in
treatment are represented. Items are slightly adapted to
the rehabilitation context. The TMQ correlates well with
professionals’ rating of the abovementioned factors what
suggests good construct validity [83].
Depressive symptoms are hypothesized to moderate
the effects of the rehabilitation outcomes. Therefore, the
level of depression is assessed by the Becks Depression
Inventory (BDI) [84]. The BDI is a well-known instrument,
and suitable for its use in pain research. It is a reliable,
valid, and widely-used instrument [85,86].
Acceptance has shown to explain a significant amount
of variance in the prediction of patient functioning and
suffering from chronic pain [87]. Acceptance is assessed
by the 10-item Acceptance and Action Questionnaire-II
(AAQ-II) [88] and scored on seven-point Likert scale
items ranging from ‘never be true’ up to ‘always true’.
The Dutch version has shown a high internal consistency
and a good validity [89].
Flexible goal-adjustment (FGA) has shown to be a
moderator in the relation between self-discrepancies and
negative emotions [90]; flexibility has shown to be of
moderating influence on pain willingness and activity
engagement [91]. FGA, a component of psychological
flexibility is measured with the Tenacious Goal Pursuit
and Flexible Goal Adjustment Scale Brandstädter and
Renner Questionnaire [92], which assesses the tendency
to adjust personal goals and standards to situational lim-
itations. It consists of 15 items with five possible answers
ranging from ‘totally agree’ up to ‘not agree at all’. The
scale’s internal consistency is satisfactory (α = 0.80) [92].
Process evaluation: MI integrity and MI fidelity
To check whether MI was implemented and delivered as
intended, an evaluation of treatment fidelity and treatment
integrity is important.
Also given the explicit emphasis in MI as a spirit
rather than a technique [93], treatment fidelity and
treatment integrity will be measured. Therefore, the MI
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be used. It has shown to be a cost-effective and reliable
tool [95,96], which is also validated to check MI fidelity
[94,97]. Feedback during the training and during
intervision sessions will be delivered based also on the
MITI. Research has also shown that proficiency rating
by skilled coders predicted treatment outcome [98-100].
To be able to do so, all pre-treatment sessions are audio
taped, and a random sample of 20% of all sessions will be
scored by one of the authors (VCM). Twenty per cent out
of those will also be scored by another skilled coder (NN)
using the abovementioned MITI instrument.
Process evaluation in participants and nurses
A process evaluation is needed to evaluate the actual deliv-
ery of our pre-treatment intervention, the process evalu-
ation focuses on the level of nurses and patients [101].
1. Patients: Patients will be asked to score their
satisfaction with pre-treatment in a set of questions
for process evaluation purposes at the end of the
pre-treatment intervention (included in the
questionnaire of T1). In case of treatment drop-out,
a patient is asked to answer the questions regarding
satisfaction with the (pre-) treatment directly after
the decision to stop, including reasons for drop-out
from treatment.
Furthermore, client-centeredness will be assessed by
the Client Centred Care Questionnaire (CCCQ). The
questionnaire was originally developed for the use in cli-
ents receiving homecare [102]. By making some minor
revisions, it can also be used in the rehabilitation setting
[103]. It has shown good psychometric qualities [102].
2. Nurses: After both pre-treatment sessions, nurses
are asked to fill in a short questionnaire. Questions
are asked about the steps taken during the
intervention, the content of the discussion during
the sessions, and the client’s active participation.
The questionnaire’s structure is based on the work
of Steckler and Linnan [101] and adapted to the
specific situation of our study.
Statistical analysis
The statistical analysis for the effect evaluation, the cost-
effectiveness evaluation and cost-utility analysis, and the
process evaluation will be described separately. Data will
be analyzed using SPSS version 17.
Effect evaluation
Baseline data will be analyzed to describe the characteristics
of all participants and to check for significant imbalances
between the two groups. Possible baseline differencesbetween the intervention group and the control group
will be tested by an independent samples t-test (normal
distribution) or Mann–Whitney U tests (non-normal
distribution) in the case of continuous variables. In the
case of dichotomous variables, a Chi-square test will
be used. In case of imbalances in prognostic factors be-
tween both randomized groups, an adjustment for
those factors will take place. The number of drop-outs
and follow-up losses in both groups will be reported
based on descriptive data. Differences in primary and
secondary outcome measures between MIP and UC
will be analyzed using repeated measurements tech-
niques and multilevel analysis. This approach is chosen
because repeated measures within individual subjects
are taken. A P value <0.05 is considered statistically
significant. Data will be analyzed according to the
intention-to-treat principle. All outcomes will be assessed
at each follow-up moment by taking into account a specific
a priori hypothesis. Additionally, per protocol analyses will
be performed to assess whether protocol deviations have
caused bias.
Moderation analysis
As secondary analyses, the working mechanisms of MI
are investigated. For testing moderation, an interaction
term of the potential moderator is constructed and ana-
lyzed by linear regression.
Economic evaluation
In the economic evaluation, cost and effects of usual
care and MIP will be calculated and compared. There-
fore, the cost per patient year (=participant year) will be
calculated. This means that all observed costs will be ex-
trapolated to a 1-year period.
The analysis will include those persons for whom at least
two of the three follow-up measurements (cost diaries)
are available.
For the cost-effectiveness analysis (CEA) the cost-
effectiveness ratio will be stated in terms of costs per im-
provement on participation (as assessed with the USER-P).
For the cost-utility analysis (CUA) the cost-utility ration
will be stated based on the cost per (Quality Adjusted Life
Year) QALY gained.
Bootstrap (5,000 times) re-sampling techniques will be
used to test for differences and uncertainty in costs and
effects between the MIP and the UC intervention.
The bootstrapped cost-effectiveness and cost-utility ratios
will be subsequently plotted in a cost-effectiveness and cost-
utility plane. The results of this study will also be depicted
in cost-effectiveness acceptability curves (CEACs) [104].
Process evaluation
Results of the questionnaires for the process evaluation
of participants and nurses will be analyzed descriptively.
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ratings of the MI-consistent behavior evaluated by the
MITI. Summary score thresholds are known for begin-
ning proficiency level and competency level [94]. A bin-
ary variable MI fidelity will be computed and used in
analyses for the effectiveness of MI as well as working
mechanisms of MI. MI fidelity is furthermore used in
mediation analyses as hypothesized mediator in the path
between the MI intervention and its effect.
Discussion
During the design of this study many choices and selec-
tions were made, and three of the most crucial ones will
be discussed.
First, we specifically chose for participation as our pri-
mary outcome measure instead of for example disability.
This is in accordance with the main outcome as sug-
gested in the ICF. The ICF is nowadays accepted in most
countries to describe and measure health and disability
[105], and the relevant aim of rehabilitation. Therefore,
it is pre-eminently adequate to use participation as primary
outcome measure in the field of rehabilitation [106]. The
choice of the other current outcome measures is congruent
with the IMMPACT recommendations [10,107,108].
Second, we chose for an attention control group
instead of a no-treatment group. Reasons for our choice
are: As we hypothesize that attention of health providers
alone could be a factor associated with motivation for
treatment, it seems important to standardize for this
factor when studying the effect of the content of a new
intervention aiming at changing motivation for treat-
ment. Therefore, we preferred the design of a trial com-
paring a MI-based and an attention control pain
education above the design of a trial with a single inter-
vention and one waiting list condition without control
intervention. Since the content of pain education is part of
usual care in the Netherlands, we designed an attention
control intervention based on the content of usual care.
For comparability reasons, the duration of the attention
control condition is identical to the MI intervention.
The quality and the efficacy of MI delivery are trouble-
some within some research reports, and the documentation
of MI fidelity is often lacking (for example, [34,109]).
Therefore, we lay a strong emphasis on the MI-training of
the care providers and an ongoing MI-fidelity check. MI
training is provided in order to make nurses adequately
proficient to learn the principles and acquire the skills of
MI [46,99,110,111]. MI integrity is checked alongside the
trial for two aims: For feedback about MI proficiency
during intervision with the nurses [95] and for the
interpretation of MI effects since intervention fidelity
is an important prerequisite for intervention effects.
To conclude, this paper describes the design of a ran-
domized controlled trial to study the effectiveness of anurse-led motivational interviewing-based pre-treatment
intervention aimed at improving and sustaining participa-
tion up until 6 months after the pain rehabilitation. The re-
sults of this study will provide evidence of the effectiveness
of this pre-treatment intervention as well as insights in
working mechanisms as well as cost-effectiveness and cost-
utility and moderating mechanisms of such an intervention
in a chronic pain population.
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